TGViewer
生物医学科技前线 生物医学科技前线 @sci_feed · 647 subscribers
Post #4478 103
新药Enliktide降低“坏”胆固醇60%
一项大型临床试验表明，新药Enliktide可以降低LDL（“坏”）胆固醇约60%，其效果与注射疗法相当。由于它可以口服，可能可以克服患者使用当前治疗方法的最大障碍。研究人员指出，即使在服用statins（一种常见的降胆固醇药物）后，许多人仍然无法…
来源: ScienceDaily ｜ 阅读全文
发布时间: 2026-03-21 20:04 GMT+8（北京时间）
#Enliktide #LDL #胆固醇 #临床试验 #降胆固醇药物
ScienceDaily New pill cuts “bad” cholesterol by 60% in major trial A new pill, enlicitide, reduced LDL (“bad”) cholesterol by about 60% in a large clinical trial, matching the power of injectable therapies. Because it’s taken orally, it could overcome one of the biggest barriers keeping patients from using current treatments.…
Open in Telegram All posts from @sci_feed
More from @sci_feed
  1. Oct 5, 2026The “glue” holding your cells together has a surprising second job Scientists have discove…
  2. Oct 5, 2026The “glue” holding your cells together has a surprising second job Scientists have discove…
  3. Oct 4, 2026This protective enzyme could help stop fatty liver disease from getting worse Scientists h…
  4. Sep 17, 2026This popular fermented food may help flush nanoplastics from the body A kimchi-derived bac…
  5. Sep 17, 2026This popular fermented food may help flush nanoplastics from the body A kimchi-derived bac…
  6. Sep 15, 2026Plague was killing entire families thousands of years before the Black Death Ancient DNA r…
Threads Profile ViewerView any public Threads profile without an account.Open ThreadLook →Writing with AI? Make it sound human.Metric37 rewrites AI drafts so they read naturally. Free AI detector, 1,500 words free.Try Metric37 →